Quick Answer
SINOVAC BIOTECH LTD reported Diluted EPS of $1.06 per share (loss) for fiscal year 2023.
SINOVAC BIOTECH LTD Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2023 | -$1.06 | -206.0% |
| 2022 | $1.00 | -98.7% |
| 2021 | $74.27 | +7556.7% |
| 2020 | $0.97 | +136.6% |
| 2019 | $0.41 | +20.6% |
| 2018 | $0.34 | -24.4% |
| 2017 | $0.45 | +4600.0% |
| 2016 | -$0.01 | +66.7% |
| 2015 | -$0.03 | +0.0% |
| 2014 | -$0.03 | -123.1% |
| 2013 | $0.13 | +750.0% |
| 2011 | -$0.02 | +87.5% |
| 2010 | -$0.16 | -134.8% |
| 2009 | $0.46 | — |
- SINOVAC BIOTECH LTD showed a decrease of -206.0% in Diluted EPS compared to the prior fiscal year.
- Over the 2009–2023 period, SINOVAC BIOTECH LTD’s diluted eps has declined by 330.4% (from $0.46 per share to $1.06 per share (loss)).
- The most recent figure is from SINOVAC BIOTECH LTD’s fiscal year 2023 report (Form 20-F), filed with the SEC on April 29, 2024.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: